<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39203975</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Effectively Evaluating a Novel Consensus Subunit Vaccine Candidate to Prevent the H9N2 Avian Influenza Virus.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">849</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12080849</ELocationID><Abstract><AbstractText>The enormous effects of avian influenza on poultry production and the possible health risks to humans have drawn much attention to this disease. The H9N2 subtype of avian influenza virus is widely prevalent among poultry, posing a direct threat to humans through infection or by contributing internal genes to various zoonotic strains of avian influenza. Despite the widespread use of H9N2 subtype vaccines, outbreaks of the virus persist due to the rapid antigenic drift and shifts in the influenza virus. As a result, it is critical to develop a broader spectrum of H9N2 subtype avian influenza vaccines and evaluate their effectiveness. In this study, a recombinant baculovirus expressing the broad-spectrum HA protein was obtained via bioinformatics analysis and a baculovirus expression system (BES). This recombinant hemagglutinin (HA) protein displayed cross-reactivity to positive sera against several subbranch H9 subtype AIVs. An adjuvant and purified HA protein were then used to create an rHA vaccine candidate. Evaluation of the vaccine demonstrated that subcutaneous immunization of the neck with the rHA vaccine candidate stimulated a robust immune response, providing complete clinical protection against various H9N2 virus challenges. Additionally, virus shedding was more effectively inhibited by rHA than by the commercial vaccine. Thus, our findings illustrate the efficacy of the rHA vaccine candidate in shielding chickens against the H9N2 virus challenge, underscoring its potential as an alternative to conventional vaccines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-6600-427X</Identifier><AffiliationInfo><Affiliation>Institute of Veterinary Immunology &amp; Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou 225300, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Food and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Nanjing 210014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Weihua</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Veterinary Immunology &amp; Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou 225300, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xuehua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Veterinary Immunology &amp; Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou 225300, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Food and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Nanjing 210014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ding</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Veterinary Immunology &amp; Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou 225300, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Food and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Nanjing 210014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Veterinary Immunology &amp; Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou 225300, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Food and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Nanjing 210014, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CX (22)3026</GrantID><Agency>Jiangsu Agricultural Science and Technology Innovation Fund</Agency><Country /></Grant><Grant><GrantID>CX (22)3031</GrantID><Agency>Jiangsu Agricultural Science and Technology Innovation Fund</Agency><Country /></Grant><Grant><GrantID>BK20220745</GrantID><Agency>Foundation Research Project of Jiangsu Province the Natural Science Fund</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">H9N2 avian influenza virus</Keyword><Keyword MajorTopicYN="N">baculovirus expression system</Keyword><Keyword MajorTopicYN="N">chicken</Keyword><Keyword MajorTopicYN="N">hemagglutinin</Keyword><Keyword MajorTopicYN="N">subunit vaccine</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39203975</ArticleId><ArticleId IdType="pmc">PMC11359011</ArticleId><ArticleId IdType="doi">10.3390/vaccines12080849</ArticleId><ArticleId IdType="pii">vaccines12080849</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li Y.T., Linster M., Mendenhall I.H., Su Y.C.F., Smith G.J.D. Avian influenza viruses in humans: Lessons from past outbreaks. Br. Med. Bull. 2019;132:81–95. doi: 10.1093/bmb/ldz036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldz036</ArticleId><ArticleId IdType="pmc">PMC6992886</ArticleId><ArticleId IdType="pubmed">31848585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lycett S.J., Duchatel F., Digard P. A brief history of bird flu. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2019;374:20180257. doi: 10.1098/rstb.2018.0257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2018.0257</ArticleId><ArticleId IdType="pmc">PMC6553608</ArticleId><ArticleId IdType="pubmed">31056053</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnaccini S., Perez D.R. H9 Influenza Viruses: An Emerging Challenge. Cold Spring Harb. Perspect. Med. 2020;10:a038588. doi: 10.1101/cshperspect.a038588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a038588</ArticleId><ArticleId IdType="pmc">PMC7263090</ArticleId><ArticleId IdType="pubmed">31871234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M., Xu L., Wang X., Liu X. Current situation of H9N2 subtype avian influenza in China. Vet. Res. 2017;48:49. doi: 10.1186/s13567-017-0453-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13567-017-0453-2</ArticleId><ArticleId IdType="pmc">PMC5603032</ArticleId><ArticleId IdType="pubmed">28915920</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat S., James J., Sadeyen J.R., Mahmood S., Everest H.J., Chang P., Walsh S.K., Byrne A.M.P., Mollett B., Lean F., et al. Coinfection of Chickens with H9N2 and H7N9 Avian Influenza Viruses Leads to Emergence of Reassortant H9N9 Virus with Increased Fitness for Poultry and a Zoonotic Potential. J. Virol. 2022;96:e0185621. doi: 10.1128/jvi.01856-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01856-21</ArticleId><ArticleId IdType="pmc">PMC8906417</ArticleId><ArticleId IdType="pubmed">35019727</ArticleId></ArticleIdList></Reference><Reference><Citation>Pusch E.A., Suarez D.L. The Multifaceted Zoonotic Risk of H9N2 Avian Influenza. Vet. Sci. 2018;5:82. doi: 10.3390/vetsci5040082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vetsci5040082</ArticleId><ArticleId IdType="pmc">PMC6313933</ArticleId><ArticleId IdType="pubmed">30248906</ArticleId></ArticleIdList></Reference><Reference><Citation>Homme P.J., Easterday B.C. Avian influenza virus infections. I. Characteristics of influenza A-turkey-Wisconsin-1966 virus. Avian Dis. 1970;14:66–74. doi: 10.2307/1588557.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/1588557</ArticleId><ArticleId IdType="pubmed">4314007</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackwood M.W., Yousef N.M.H., Hilt D.A. Further development and use of a molecular serotype identification test for infectious bronchitis virus. Avian Diseases. 1997;41:105–110. doi: 10.2307/1592449.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/1592449</ArticleId><ArticleId IdType="pubmed">9087326</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellahi S., Nassik S., Maaroufi I., Tligui N.S., Touzani C.D., Rawi T., Delvecchio A., Ducatez M.F., El Houadfi M. Pathogenesis of Avian Influenza Virus Subtype H9N2 in Turkeys and Evaluation of Inactivated Vaccine Efficacy. Avian Diseases. 2021;65:46–51. doi: 10.1637/aviandiseases-D-20-00067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1637/aviandiseases-D-20-00067</ArticleId><ArticleId IdType="pubmed">34339121</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Sun J., Lv X., Wang Y., Li Y., Li M., Liu W., Zhi M., Yang X., Fu T., et al. Novel Reassortant Avian Influenza A(H9N2) Virus Isolate in Migratory Waterfowl in Hubei Province, China. Front. Microbiol. 2020;11:220. doi: 10.3389/fmicb.2020.00220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00220</ArticleId><ArticleId IdType="pmc">PMC7031422</ArticleId><ArticleId IdType="pubmed">32117193</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi Y., Li J., Li S., Fu G., Jin T., Zhang C., Yang Y., Ma Z., Tian W., Li J., et al. Dominant subtype switch in avian influenza viruses during 2016-2019 in China. Nat. Commun. 2020;11:5909. doi: 10.1038/s41467-020-19671-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19671-3</ArticleId><ArticleId IdType="pmc">PMC7679419</ArticleId><ArticleId IdType="pubmed">33219213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Liu X., Wang X. The immune system of chicken and its response to H9N2 avian influenza virus. Vet. Q. 2023;43:1–14. doi: 10.1080/01652176.2023.2228360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01652176.2023.2228360</ArticleId><ArticleId IdType="pmc">PMC10324433</ArticleId><ArticleId IdType="pubmed">37357919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrell E.M., Wan H.Q., Araya Y., Song H.C., Perez D.R. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc. Natl. Acad. Sci. USA. 2009;106:7565–7570. doi: 10.1073/pnas.0900877106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900877106</ArticleId><ArticleId IdType="pmc">PMC2670882</ArticleId><ArticleId IdType="pubmed">19380727</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y.P., Qin K., Wang J.J., Pu J.A., Tang Q.D., Hu Y.X., Bi Y.H., Zhao X.L., Yang H.C., Shu Y.L., et al. High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proc. Natl. Acad. Sci. USA. 2011;108:4164–4169. doi: 10.1073/pnas.1019109108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1019109108</ArticleId><ArticleId IdType="pmc">PMC3054021</ArticleId><ArticleId IdType="pubmed">21368167</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C., Zhao P., Chu J., Zhu J., Li Q., Zhao H., Li Y., Xin L., Yang X., Xie S., et al. Characterization of four novel H5N6 avian influenza viruses with the internal genes from H5N1 and H9N2 viruses and experimental challenge of chickens vaccinated with current commercially available H5 vaccines. Transbound. Emerg. Dis. 2022;69:1438–1448. doi: 10.1111/tbed.14110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.14110</ArticleId><ArticleId IdType="pubmed">33872465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam T.T., Wang J., Shen Y., Zhou B., Duan L., Cheung C.L., Ma C., Lycett S.J., Leung C.Y., Chen X., et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature. 2013;502:241–244. doi: 10.1038/nature12515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12515</ArticleId><ArticleId IdType="pmc">PMC3801098</ArticleId><ArticleId IdType="pubmed">23965623</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloren K.K.S., Lee T., Kwon J.J., Song M.S. Molecular Markers for Interspecies Transmission of Avian Influenza Viruses in Mammalian Hosts. Int. J. Mol. Sci. 2017;18:2706. doi: 10.3390/ijms18122706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18122706</ArticleId><ArticleId IdType="pmc">PMC5751307</ArticleId><ArticleId IdType="pubmed">29236050</ArticleId></ArticleIdList></Reference><Reference><Citation>Um S., Siegers J.Y., Sar B., Chin S., Patel S., Bunnary S., Hak M., Sor S., Sokhen O., Heng S., et al. Human Infection with Avian Influenza A(H9N2) Virus, Cambodia, February 2021. Emerg. Infect. Dis. 2021;27:2742–2745. doi: 10.3201/eid2710.211039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2710.211039</ArticleId><ArticleId IdType="pmc">PMC8462329</ArticleId><ArticleId IdType="pubmed">34546164</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B.S., Li L.J., Zhu Q., Wang Z., Yuan P., Zhou G.D., Shi W.J., Chu X.F., Jiang S.J., Xie Z.J. Co-infection of H9N2 influenza virus and contributes to the development of hemorrhagic pneumonia in mink. Vet. Microbiol. 2020;240:108542. doi: 10.1016/j.vetmic.2019.108542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2019.108542</ArticleId><ArticleId IdType="pubmed">31902499</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Zhuang Q., Wang S., Jiang W., Jin J., Peng C., Hou G., Li J., Yu J., Yu X., et al. Control of avian influenza in China: Strategies and lessons. Transbound. Emerg. Dis. 2020;67:1463–1471. doi: 10.1111/tbed.13515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.13515</ArticleId><ArticleId IdType="pubmed">32065513</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J.Z., Zhou Y., Pu J., Liu L.T. Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China. Life. 2022;12:1326. doi: 10.3390/life12091326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12091326</ArticleId><ArticleId IdType="pmc">PMC9505450</ArticleId><ArticleId IdType="pubmed">36143363</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Jin T., Cui Y., Pu X., Li J., Xu J., Liu G., Jia H., Liu D., Song S., et al. Influenza H7N9 and H9N2 viruses: Coexistence in poultry linked to human H7N9 infection and genome characteristics. J. Virol. 2014;88:3423–3431. doi: 10.1128/JVI.02059-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02059-13</ArticleId><ArticleId IdType="pmc">PMC3957952</ArticleId><ArticleId IdType="pubmed">24403589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.H., Hong K.J., Kim H., Nam J.H. Influenza vaccines: Past, present, and future. Rev. Med. Virol. 2022;32:e2243. doi: 10.1002/rmv.2243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2243</ArticleId><ArticleId IdType="pmc">PMC8209895</ArticleId><ArticleId IdType="pubmed">33949021</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhao D., Zhang J., Huang X., Han K., Liu Q., Yang J., Zhang L., Li Y. Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks. Vaccines. 2023;11:596. doi: 10.3390/vaccines11030596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030596</ArticleId><ArticleId IdType="pmc">PMC10053827</ArticleId><ArticleId IdType="pubmed">36992180</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Zhang B., Yao J., Ruan W. A new H9 influenza virus mRNA vaccine elicits robust protective immunity against infection. Vaccine. 2023;41:2905–2913. doi: 10.1016/j.vaccine.2023.03.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.03.049</ArticleId><ArticleId IdType="pubmed">37005103</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Quan K., Chen Z., Hu Q., Nie M., Xu N., Gao R., Wang X., Qin T., Chen S., et al. The emergence of new antigen branches of H9N2 avian influenza virus in China due to antigenic drift on hemagglutinin through antibody escape at immunodominant sites. Emerg. Microbes Infect. 2023;12:2246582. doi: 10.1080/22221751.2023.2246582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2246582</ArticleId><ArticleId IdType="pmc">PMC10444018</ArticleId><ArticleId IdType="pubmed">37550992</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S., Nie Z., Che Y., Shu J., Wu S., He Y., Wu Y., Qian H., Feng H., Zhang Q. The Chinese Hamster Ovary Cell-Based H9 HA Subunit Avian Influenza Vaccine Provides Complete Protection against the H9N2 Virus Challenge in Chickens. Viruses. 2024;16:163. doi: 10.3390/v16010163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16010163</ArticleId><ArticleId IdType="pmc">PMC10821000</ArticleId><ArticleId IdType="pubmed">38275973</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissett S.L., Roy P. Multi-Gene Recombinant Baculovirus Expression Systems: From Inception to Contemporary Applications. Viruses. 2024;16:492. doi: 10.3390/v16040492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16040492</ArticleId><ArticleId IdType="pmc">PMC11054102</ArticleId><ArticleId IdType="pubmed">38675835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Q., Liu J., Wei Y., Wei X. Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development. Vaccines. 2023;11:1218. doi: 10.3390/vaccines11071218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11071218</ArticleId><ArticleId IdType="pmc">PMC10386281</ArticleId><ArticleId IdType="pubmed">37515034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishack S., Lipner S.R. Bioinformatics and immunoinformatics to support COVID-19 vaccine development. J. Med. Virol. 2021;93:5209–5211. doi: 10.1002/jmv.27017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27017</ArticleId><ArticleId IdType="pmc">PMC8251214</ArticleId><ArticleId IdType="pubmed">33851735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah A., Waqas M., Aziz S., Rahman S.U., Khan S., Khalid A., Abdalla A.N., Uddin J., Halim S.A., Khan A., et al. Bioinformatics and immunoinformatics approach to develop potent multi-peptide vaccine for coxsackievirus B3 capable of eliciting cellular and humoral immune response. Int. J. Biol. Macromol. 2023;239:124320. doi: 10.1016/j.ijbiomac.2023.124320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2023.124320</ArticleId><ArticleId IdType="pubmed">37004935</ArticleId></ArticleIdList></Reference><Reference><Citation>Caceres C.J., Rajao D.S., Perez D.R. Airborne Transmission of Avian Origin H9N2 Influenza A Viruses in Mammals. Viruses. 2021;13:1919. doi: 10.3390/v13101919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101919</ArticleId><ArticleId IdType="pmc">PMC8540072</ArticleId><ArticleId IdType="pubmed">34696349</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X., Liu Q., Niu S., Huang D., Yan D., Teng Q., Li X., Beerens N., Forlenza M., de Jong M.C.M., et al. Efficacy of a recombinant turkey herpesvirus (H9) vaccine against H9N2 avian influenza virus in chickens with maternal-derived antibodies. Front. Microbiol. 2022;13:1107975. doi: 10.3389/fmicb.2022.1107975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1107975</ArticleId><ArticleId IdType="pmc">PMC9909025</ArticleId><ArticleId IdType="pubmed">36777028</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P., Lu J., Zhang X., Mei M., Feng L., Peng D., Hou J., Kang S.M., Liu X., Tang Y. Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses. Front. Immunol. 2017;8:1649. doi: 10.3389/fimmu.2017.01649.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01649</ArticleId><ArticleId IdType="pmc">PMC5711813</ArticleId><ArticleId IdType="pubmed">29230222</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., Ye H., Qiu W., Lin H., Chen Y., Zhang H., Liao M. Phylogenetic classification of hemagglutinin gene of H9N2 avian influenza viruses isolated in China during 2012-2016 and evaluation of selected candidate vaccine strains. Poult. Sci. 2018;97:3023–3030. doi: 10.3382/ps/pey154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3382/ps/pey154</ArticleId><ArticleId IdType="pubmed">29931183</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J., Li Y.X., Dong M.Y., Guo Z.W., Luo Y.W., Li N.L., Zhao Y., Li M., Lin Y., Xu J., et al. Evolution of prevalent H9N2 subtype of avian influenza virus during 2019 to 2022 for the development of a control strategy in China. Poult. Sci. 2023;102:102957. doi: 10.1016/j.psj.2023.102957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psj.2023.102957</ArticleId><ArticleId IdType="pmc">PMC10448327</ArticleId><ArticleId IdType="pubmed">37573848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei K., Li Y. Global genetic variation and transmission dynamics of H9N2 avian influenza virus. Transbound. Emerg. Dis. 2018;65:504–517. doi: 10.1111/tbed.12733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.12733</ArticleId><ArticleId IdType="pubmed">29086491</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Liu K., Guo Y., Pei Y., Chen X., Lu X., Gao R., Chen Y., Gu M., Hu J., et al. Emergence of a new designated clade 16 with significant antigenic drift in hemagglutinin gene of H9N2 subtype avian influenza virus in eastern China. Emerg. Microbes Infect. 2023;12:2249558. doi: 10.1080/22221751.2023.2249558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2249558</ArticleId><ArticleId IdType="pmc">PMC10467529</ArticleId><ArticleId IdType="pubmed">37585307</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C.L., Liao Z.H., Shen Y., Wang H., Lin W.C., Li H., Chen W.G., Xie Q.M. Assessing the efficacy of a recombinant H9N2 avian influenza virus-inactivated vaccine. Poult. Sci. 2020;99:4334–4342. doi: 10.1016/j.psj.2020.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psj.2020.06.012</ArticleId><ArticleId IdType="pmc">PMC7598126</ArticleId><ArticleId IdType="pubmed">32867977</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Zeng X., Cui P., Yan C., Chen H. Alarming situation of emerging H5 and H7 avian influenza and effective control strategies. Emerg. Microbes Infect. 2023;12:2155072. doi: 10.1080/22221751.2022.2155072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2155072</ArticleId><ArticleId IdType="pmc">PMC9754034</ArticleId><ArticleId IdType="pubmed">36458831</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayedahmed E.E., Elkashif A., Alhashimi M., Sambhara S., Mittal S.K. Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines. Vaccines. 2020;8:574. doi: 10.3390/vaccines8040574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines8040574</ArticleId><ArticleId IdType="pmc">PMC7712206</ArticleId><ArticleId IdType="pubmed">33019589</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Fong Legaspi S.L., Schwartzman L.M., Gygli S.M., Sheng Z.M., Freeman A.D., Matthews L.M., Xiao Y., Ramuta M.D., Batchenkova N.A., et al. An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets. Sci. Transl. Med. 2022;14:eabo2167. doi: 10.1126/scitranslmed.abo2167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo2167</ArticleId><ArticleId IdType="pmc">PMC11022527</ArticleId><ArticleId IdType="pubmed">35857640</ArticleId></ArticleIdList></Reference><Reference><Citation>Guthmiller J.J., Han J., Utset H.A., Li L., Lan L.Y., Henry C., Stamper C.T., McMahon M., O’Dell G., Fernandez-Quintero M.L., et al. Broadly neutralizing antibodies target a haemagglutinin anchor epitope. Nature. 2022;602:314–320. doi: 10.1038/s41586-021-04356-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04356-8</ArticleId><ArticleId IdType="pmc">PMC8828479</ArticleId><ArticleId IdType="pubmed">34942633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Zhang Q., Peng P., Li R., Li J., Wang X., Gu M., Hu Z., Hu S., Liu X., et al. Baculovirus-derived influenza virus-like particle confers complete protection against lethal H7N9 avian influenza virus challenge in chickens and mice. Vet. Microbiol. 2022;264:109306. doi: 10.1016/j.vetmic.2021.109306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2021.109306</ArticleId><ArticleId IdType="pubmed">34923247</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wang J., Zhang J., Ly H. Advances in Development and Application of Influenza Vaccines. Front. Immunol. 2021;12:711997. doi: 10.3389/fimmu.2021.711997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.711997</ArticleId><ArticleId IdType="pmc">PMC8313855</ArticleId><ArticleId IdType="pubmed">34326849</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Zhao T., Wang L., Yang Z., Luo C., Li M., Luo H., Sun C., Yan H., Shu Y. A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses. NPJ Vaccines. 2023;8:132. doi: 10.1038/s41541-023-00728-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-023-00728-5</ArticleId><ArticleId IdType="pmc">PMC10485063</ArticleId><ArticleId IdType="pubmed">37679361</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>